Published in Anal Biochem on April 20, 2012
Samples From Human Subjects to Facilitate Basic, Translational and Clinical Research | NCT03253705
Ascorbic acid: chemistry, biology and the treatment of cancer. Biochim Biophys Acta (2012) 1.89
Parenteral ascorbate as a cancer therapeutic: a reassessment based on pharmacokinetics. Antioxid Redox Signal (2013) 0.97
Low Red Blood Cell Vitamin C Concentrations Induce Red Blood Cell Fragility: A Link to Diabetes Via Glucose, Glucose Transporters, and Dehydroascorbic Acid. EBioMedicine (2015) 0.92
Intestinal dehydroascorbic acid (DHA) transport mediated by the facilitative sugar transporters, GLUT2 and GLUT8. J Biol Chem (2013) 0.88
Vitamin C: the known and the unknown and Goldilocks. Oral Dis (2016) 0.82
Treatment of Pancreatic Cancer with Pharmacological Ascorbate. Curr Pharm Biotechnol (2015) 0.78
Direct spectrophotometric measurement of supra-physiological levels of ascorbate in plasma. Redox Biol (2016) 0.77
(1)H NMR-Based Analysis of Serum Metabolites in Monocrotaline-Induced Pulmonary Arterial Hypertensive Rats. Dis Markers (2016) 0.75
Chemical Transport Knockout for Oxidized Vitamin C, Dehydroascorbic Acid, Reveals Its Functions in vivo. EBioMedicine (2017) 0.75
Duration of red-cell storage and complications after cardiac surgery. N Engl J Med (2008) 10.04
DISTRIBUTION OF ASCORBIC ACID IN THE BLOOD AND ITS NUTRITIONAL SIGNIFICANCE. J Clin Invest (1940) 6.38
Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. JAMA (2010) 5.80
Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proc Natl Acad Sci U S A (1996) 4.45
Evolution of adverse changes in stored RBCs. Proc Natl Acad Sci U S A (2007) 3.58
Clinical consequences of red cell storage in the critically ill. Transfusion (2006) 3.57
Erythrocyte Glut1 triggers dehydroascorbic acid uptake in mammals unable to synthesize vitamin C. Cell (2008) 2.84
S-nitrosohemoglobin deficiency: a mechanism for loss of physiological activity in banked blood. Proc Natl Acad Sci U S A (2007) 2.77
Catalytic metals, ascorbate and free radicals: combinations to avoid. Radiat Res (1996) 2.68
In the absence of catalytic metals ascorbate does not autoxidize at pH 7: ascorbate as a test for catalytic metals. J Biochem Biophys Methods (1988) 2.22
A new recommended dietary allowance of vitamin C for healthy young women. Proc Natl Acad Sci U S A (2001) 2.12
Aortic wall damage in mice unable to synthesize ascorbic acid. Proc Natl Acad Sci U S A (2000) 1.83
Protection and recycling of alpha-tocopherol in human erythrocytes by intracellular ascorbic acid. Arch Biochem Biophys (1998) 1.72
Red cell changes during storage. Transfus Apher Sci (2010) 1.68
Glucose transporter isoforms GLUT1 and GLUT3 transport dehydroascorbic acid. J Biol Chem (1997) 1.60
STUDIES IN ASCORBIC ACID WITH ESPECIAL REFERENCE TO THE WHITE LAYER. I. DESCRIPTION OF METHOD AND COMPARISON OF ASCORBIC ACID LEVELS IN WHOLE BLOOD, PLASMA, RED CELLS, AND WHITE LAYER. J Clin Invest (1945) 1.51
An improved method for determination of L-ascorbic acid and L-dehydroascorbic acid in blood plasma. Clin Chim Acta (1980) 1.47
Vitamin C: a concentration-function approach yields pharmacology and therapeutic discoveries. Adv Nutr (2011) 1.45
Ascorbic acid and dehydroascorbic acid analyses in biological samples. Anal Biochem (1992) 1.31
Ascorbic acid and dehydroascorbic acid measurements in human plasma and serum. Am J Clin Nutr (1991) 1.27
Erythrocyte ascorbate recycling: antioxidant effects in blood. Free Radic Biol Med (1998) 1.20
Analysis of ascorbic acid and dehydroascorbic acid in biological samples. Methods Enzymol (1999) 1.19
6-Bromo-6-deoxy-L-ascorbic acid: an ascorbate analog specific for Na+-dependent vitamin C transporter but not glucose transporter pathways. J Biol Chem (2004) 1.16
Distribution of ascorbic acid in normal and leukaemic human blood. Biochem J (1958) 1.11
Maturational loss of the vitamin C transporter in erythrocytes. Biochem Biophys Res Commun (2007) 1.11
Ascorbate function and metabolism in the human erythrocyte. Front Biosci (1998) 1.09
Human erythrocyte membranes contain a cytochrome b561 that may be involved in extracellular ascorbate recycling. J Biol Chem (2006) 0.99
Specificity of ascorbate analogs for ascorbate transport. Synthesis and detection of [(125)I]6-deoxy-6-iodo-L-ascorbic acid and characterization of its ascorbate-specific transport properties. J Biol Chem (1999) 0.98
Dehydroascorbic acid. J Chromatogr A (2000) 0.90
Redox metabolism of vitamin C in blood of normal and malaria-infected mice. Biochim Biophys Acta (1993) 0.89
Enzyme-dependent ascorbate recycling in human erythrocytes: role of thioredoxin reductase. Free Radic Biol Med (1998) 0.87
Vitamin C redox reactions in blood of normal and malaria-infected mice studied with isoascorbate as a nonisotopic marker. Free Radic Biol Med (1995) 0.85
Ascorbate levels in red blood cells and urine in patients with sickle cell anemia. Am J Hematol (2000) 0.83
Purification and characterization of a glutathione dependent dehydroascorbate reductase from human erythrocytes. Biochem Biophys Res Commun (1996) 0.82
The whole structure of the human nonfunctional L-gulono-gamma-lactone oxidase gene--the gene responsible for scurvy--and the evolution of repetitive sequences thereon. J Nutr Sci Vitaminol (Tokyo) (2003) 0.81
A specific high-performance liquid chromatography assay for dehydroascorbic acid shows an increased content in CLL lymphocytes. Anal Biochem (1983) 0.78
Rapid and sensitive determination of dehydroascorbic acid in addition to ascorbic acid by reversed-phase high-performance liquid chromatography using a post-column reduction system. J Chromatogr (1987) 0.78
Quantitative analysis of ascorbic acid and dehydroascorbic acid by high-performance liquid chromatography. Anal Biochem (1981) 0.78
Simultaneous determination of ascorbic acid and dehydroascorbic acid in cultures of C3H/10T1/2 cells. In Vitro Cell Dev Biol (1988) 0.77
A study of the normal distribution of ascorbic acid between the red cells and plasma of human blood. J Biol Chem (1947) 0.77
Functions of vitamin C as a mediator of transmembrane electron transport in blood cells and related cell culture models. Antioxid Redox Signal (2000) 0.77
The determination of vitamin C in normal human plasma and erythrocytes. Clin Chim Acta (1956) 0.77
[Preparation of chemically modified carbon electrodes by anodization in 1-alkanols and their application to electrochemical analysis]. Yakugaku Zasshi (2000) 0.77
Monitoring of vitamin C species in aqueous solution by flow injection analysis coupled with an on-line separation with reversed-phase column. Talanta (2009) 0.76
Beyond prejudice: are negative evaluations the problem and is getting us to like one another more the solution? Behav Brain Sci (2012) 18.61
Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. J Natl Cancer Inst (2002) 4.33
Vitamin C pharmacokinetics: implications for oral and intravenous use. Ann Intern Med (2004) 4.30
Effect of a decision aid on knowledge and treatment decision making for breast cancer surgery: a randomized trial. JAMA (2004) 4.18
Vitamin C as an antioxidant: evaluation of its role in disease prevention. J Am Coll Nutr (2003) 3.34
Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues. Proc Natl Acad Sci U S A (2005) 3.30
Ascorbic-acid transporter Slc23a1 is essential for vitamin C transport into the brain and for perinatal survival. Nat Med (2002) 2.90
Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo. Proc Natl Acad Sci U S A (2007) 2.71
Helping patients make informed choices: a randomized trial of a decision aid for adjuvant chemotherapy in lymph node-negative breast cancer. J Natl Cancer Inst (2003) 2.51
Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice. Proc Natl Acad Sci U S A (2008) 2.50
Major contribution of tubular secretion to creatinine clearance in mice. Kidney Int (2009) 2.46
The Kitty Genovese murder and the social psychology of helping: the parable of the 38 witnesses. Am Psychol (2007) 2.23
Randomized trial of high-dose chemotherapy with autologous peripheral-blood stem-cell support compared with standard-dose chemotherapy in women with metastatic breast cancer: NCIC MA.16. J Clin Oncol (2007) 2.15
Oxalic acid excretion after intravenous ascorbic acid administration. Metabolism (2009) 2.14
Randomized trial comparing two fractionation schedules for patients with localized prostate cancer. J Clin Oncol (2005) 2.06
Warfarin dose assessment every 4 weeks versus every 12 weeks in patients with stable international normalized ratios: a randomized trial. Ann Intern Med (2011) 1.98
Vitamin C: intravenous use by complementary and alternative medicine practitioners and adverse effects. PLoS One (2010) 1.92
High-dose parenteral ascorbate enhanced chemosensitivity of ovarian cancer and reduced toxicity of chemotherapy. Sci Transl Med (2014) 1.91
Clinical practice guidelines for the care and treatment of breast cancer: follow-up after treatment for breast cancer (summary of the 2005 update). CMAJ (2005) 1.89
Human adrenal glands secrete vitamin C in response to adrenocorticotrophic hormone. Am J Clin Nutr (2007) 1.60
Regiospecific synthesis of 3-substituted imidazo[1,2-a]pyridines, imidazo[1,2-a]pyrimidines, and imidazo[1,2-c]pyrimidine. J Org Chem (2003) 1.58
Mechanisms of ascorbate-induced cytotoxicity in pancreatic cancer. Clin Cancer Res (2010) 1.57
Randomized trial comparing iridium implant plus external-beam radiation therapy with external-beam radiation therapy alone in node-negative locally advanced cancer of the prostate. J Clin Oncol (2005) 1.54
Coverage with evidence development: the Ontario experience. Int J Technol Assess Health Care (2011) 1.53
Inhibition of the intestinal glucose transporter GLUT2 by flavonoids. FASEB J (2006) 1.53
Clinical practice guidelines for the care and treatment of breast cancer: 15. Treatment for women with stage III or locally advanced breast cancer. CMAJ (2004) 1.51
Using administrative databases to measure waiting times for patients undergoing major cancer surgery in Ontario, 1993-2000. Can J Surg (2005) 1.49
Clinical practice guidelines for the care and treatment of breast cancer: 16. Locoregional post-mastectomy radiotherapy. CMAJ (2004) 1.46
Central venous catheter care for the patient with cancer: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol (2013) 1.46
Intravenously administered vitamin C as cancer therapy: three cases. CMAJ (2006) 1.43
Subversion of cellular autophagy machinery by hepatitis B virus for viral envelopment. J Virol (2011) 1.41
Hypoxia-inducible factor-1alpha stabilization in nonhypoxic conditions: role of oxidation and intracellular ascorbate depletion. Mol Biol Cell (2007) 1.41
Association of alpha2a and beta2 adrenoceptor expression with clinical outcome in breast cancer. Curr Med Res Opin (2014) 1.41
Incidence and prognostic impact of amenorrhea during adjuvant therapy in high-risk premenopausal breast cancer: analysis of a National Cancer Institute of Canada Clinical Trials Group Study--NCIC CTG MA.5. J Clin Oncol (2005) 1.40
Phase I evaluation of intravenous ascorbic acid in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer. PLoS One (2012) 1.35
Vitamin C transporter Slc23a1 links renal reabsorption, vitamin C tissue accumulation, and perinatal survival in mice. J Clin Invest (2010) 1.33
Comparison of the genomic structure and variation in the two human sodium-dependent vitamin C transporters, SLC23A1 and SLC23A2. Hum Genet (2004) 1.27
Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancer. Free Radic Biol Med (2011) 1.27
Lessons learned from the Decision Board: a unique and evolving decision aid. Health Expect (2000) 1.25
6-Bromo-6-deoxy-L-ascorbic acid: an ascorbate analog specific for Na+-dependent vitamin C transporter but not glucose transporter pathways. J Biol Chem (2004) 1.16
Genomic and functional analysis of the sodium-dependent vitamin C transporter SLC23A1-SVCT1. Genes Nutr (2007) 1.16
Venous thrombosis in cancer patients: insights from the FRONTLINE survey. Oncologist (2003) 1.13
Flavonoid inhibition of sodium-dependent vitamin C transporter 1 (SVCT1) and glucose transporter isoform 2 (GLUT2), intestinal transporters for vitamin C and Glucose. J Biol Chem (2002) 1.13
Influence of hospital characteristics on operative death and survival of patients after major cancer surgery in Ontario. Can J Surg (2006) 1.12
High-dose oral vitamin C partially replenishes vitamin C levels in patients with Type 2 diabetes and low vitamin C levels but does not improve endothelial dysfunction or insulin resistance. Am J Physiol Heart Circ Physiol (2005) 1.11
Standard-dose vs high-dose multivitamin supplements for HIV. JAMA (2013) 1.08
Genetic variation in the sodium-dependent vitamin C transporters, SLC23A1, and SLC23A2 and risk for preterm delivery. Am J Epidemiol (2005) 1.08
Radiation therapy and tamoxifen: concurrent or sequential? That is the question. J Clin Oncol (2004) 1.06
Cloning and functional characterization of the mouse fructose transporter, GLUT5. Biochim Biophys Acta (2002) 1.05
Hemoglobin and plasma vitamin C levels in patients on peritoneal dialysis. Perit Dial Int (2010) 0.99
Viperin inhibits hepatitis C virus replication by interfering with binding of NS5A to host protein hVAP-33. J Gen Virol (2011) 0.99
The role of mannosylated enzyme and the mannose receptor in enzyme replacement therapy. Am J Hum Genet (2005) 0.98
Parenteral ascorbate as a cancer therapeutic: a reassessment based on pharmacokinetics. Antioxid Redox Signal (2013) 0.97
Genetic variation in sodium-dependent vitamin C transporters SLC23A1 and SLC23A2 and risk of advanced colorectal adenoma. Nutr Cancer (2008) 0.96
Vitamins C and E and the prevention of preeclampsia. N Engl J Med (2006) 0.96
The experience of conducting Mortality and Morbidity reviews in a pediatric interventional radiology service: a retrospective study. J Vasc Interv Radiol (2008) 0.93
Impaired adrenal catecholamine system function in mice with deficiency of the ascorbic acid transporter (SVCT2). FASEB J (2003) 0.92
Acetic-acid-mediated miscibility toward electrospinning homogeneous composite nanofibers of GT/PCL. Biomacromolecules (2012) 0.91
Bystander responses to a violent incident in an immersive virtual environment. PLoS One (2013) 0.90
Intestinal dehydroascorbic acid (DHA) transport mediated by the facilitative sugar transporters, GLUT2 and GLUT8. J Biol Chem (2013) 0.88
Vitamin and mineral supplements in the primary prevention of cardiovascular disease and cancer. Ann Intern Med (2014) 0.88
Fruit and vegetables: think variety, go ahead, eat! Am J Clin Nutr (2008) 0.87
Evidence-based approach to the introduction of positron emission tomography in ontario, Canada. J Clin Oncol (2009) 0.87
Short-term and long-term vitamin C supplementation in humans dose-dependently increases the resistance of plasma to ex vivo lipid peroxidation. Arch Biochem Biophys (2004) 0.86
Ascorbic acid kills Epstein-Barr virus positive Burkitt lymphoma cells and Epstein-Barr virus transformed B-cells in vitro, but not in vivo. Leuk Lymphoma (2012) 0.86
Risk of acute leukemia following epirubicin-based adjuvant chemotherapy: a report from the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol (2003) 0.85
Comparative effectiveness research in oncology: an overview. J Clin Oncol (2012) 0.85
Measurement of plasma volume using fluorescent silica-based nanoparticles. J Appl Physiol (1985) (2011) 0.83
Prostate imaging modalities that can be used for complementary and alternative medicine clinical studies. Urol Clin North Am (2011) 0.83
Reduction of atherosclerotic plaques by lysosomal acid lipase supplementation. Arterioscler Thromb Vasc Biol (2003) 0.83
Transparent nanowire network electrode for textured semiconductors. Small (2012) 0.82
Comment re: Vitamin C antagonizes the cytotoxic effects of chemotherapy. Cancer Res (2009) 0.82
Vitamin C: working on the x-axis. Am J Clin Nutr (2009) 0.81
Social meaning of ambiguous sounds influences retrospective duration judgments. Psychol Sci (2013) 0.81
Functional expression and characterization of an acidic actinoporin from sea anemone Sagartia rosea. Biochem Biophys Res Commun (2003) 0.80
Helping to improve the group stereotype: on the strategic dimension of prosocial behavior. Pers Soc Psychol Bull (2007) 0.80
Ocular surface squamous neoplasia in an anophthalmic socket 60 years after enucleation. Surv Ophthalmol (2011) 0.80
More evidence that locoregional radiation therapy improves survival: what should we do? J Natl Cancer Inst (2005) 0.79
Accuracy and safety of (99m)Tc-labeled anti-D-dimer (DI-80B3) Fab' fragments (ThromboView®) in the diagnosis of deep vein thrombosis: a phase II study. Thromb Res (2012) 0.79
Enoxaparin in the treatment of deep vein thrombosis with or without pulmonary embolism: an individual patient data meta-analysis. Chest (2005) 0.79
Epilogue: the peril and the promise of comparative effectiveness research in oncology. J Clin Oncol (2012) 0.78
The Initial Health Assessment: an intervention to identify the supportive care needs of cancer patients. Support Care Cancer (2003) 0.78
Imaging: PET-CT imaging in non-small-cell lung cancer. Nat Rev Clin Oncol (2009) 0.78
Structures of a pan-specific antagonist antibody complexed to different isoforms of TGFβ reveal structural plasticity of antibody-antigen interactions. Protein Sci (2014) 0.77
Antioxidant supplements and cardiovascular disease in men. JAMA (2009) 0.77
Economics of preoperative radiotherapy with total mesorectal excision: what can we learn from the Dutch experience? J Clin Oncol (2003) 0.77
High-dose ascorbate with low-dose amphotericin B attenuates severity of disease in a model of the reappearance of candidemia during sepsis in the mouse. Am J Physiol Regul Integr Comp Physiol (2015) 0.76